Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease

Open access

Abstract

Many studies highlight the potential link between the chronic degenerative Alzheimer’s disease and the infection by the herpes simplex virus type-1 (HSV-1). However, the molecular mechanisms making possible this HSV-1-dependent process remain to be understood. Using neuronal cells expressing the wild type form of amyloid precursor protein (APP) infected by HSV-1, we characterized a representative cellular model of the early stage of the sporadic form of the disease and unraveled a molecular mechanism sustaining this HSV-1- Alzheimer’s disease interplay. Here, we show that HSV-1 induces caspase-dependent production of the 42 amino-acid long amyloid peptide (Aβ42) oligomers followed by their accumulation in neuronal cells. Aβ42 oligomers and activated caspase 3 (casp3A) concentrate into intracytoplasmic structures observed in Alzheimer’s disease neuronal cells called aggresomes. This casp3A accumulation in aggresomes during HSV-1 infection limits the execution of apoptosis until its term, similarly to an abortosis-like event occurring in Alzheimer’s disease neuronal cells patients. Indeed, this particular HSV-1 driven cellular context, representative of early stages of the disease, sustains a failed apoptosis mechanism that could explain the chronic amplification of Aβ42 production characteristic of Alzheimer’s disease patients. Finally, we show that combination of flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID), with caspase inhibitor reduced drastically HSV-1-induced Aβ42 oligomers production. This provided mechanistic insights supporting the conclusion of clinical trials showing that NSAIDs reduced Alzheimer’s disease incidence in early stage of the disease. Therefore, from our study we propose that caspase-dependent production of Aβ42 oligomers together with the abortosis-like event represents a vicious circle in early Alzheimer’s disease stages leading to a chronic amplification of Aβ42 oligomers that contributes to the establishment of degenerative disorder like Alzheimer’s disease in patients infected by HSV-1. Interestingly this process could be targeted by an association of NSAID with caspase inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-023-02376-8

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Decreasing of APP amounts during infection. A Measurement of accumulation of APP mRNA by RT-qPCR at NI, 6 and 9 h p.i with a set of primers recognizing the sequence around the region coding for β amyloid. B Box-and-Whisker plot of gene expression measurements for APP at NI and 9 h.p.i, n = 5, SAM ***p-value < 0.001. C WB analysis of APP at NI, 3, 6 and 9 h.p.i using anti-APP Cter antibody (A8717-Sigma). Viral protein US11 as control of infection.
Fig. 1 Decreasing of APP amounts during infection. A Measurement of accumulation of APP mRNA by RT-qPCR at NI, 6 and 9 h p.i with a set of primers recognizing the sequence around the region coding for β amyloid. B Box-and-Whisker plot of gene expression measurements for APP at NI and 9 h.p.i, n = 5, SAM ***p-value < 0.001. C WB analysis of APP at NI, 3, 6 and 9 h.p.i using anti-APP Cter antibody (A8717-Sigma). Viral protein US11 as control of infection.CC BY · PubMed Central
Fig. 2 APP post-translational maturation occurs via non amyloid and amyloid pathways during infection. A Representation of APP-derived isoforms detected by anti-APP C-Ter antibody directed against the C terminal extremity of APP. B, C FACS analysis of number of APP-derived isoforms positive cells at NI and 9 h p.i. (%) using anti-APP Cter antibody (171610-Calbiochem) ****p-value < 0.0001 n = 1, 2 replicats. D WB analysis of APP-derived isoforms at NI, 3, 6 and 9 h.p.i using anti-APP Cter antibody (171610-Calbiochem). E Representation of Aβ42 detected by anti-Aβ42 specific antibody directed against C terminal cleaved extremity. F, G FACS analysis of number of Aβ42 oligomers positive cells at NI and 9 h p.i. (%) using anti-Aβ42 C ter antibody (A1976-Sigma) ****p-value < 0.0001 n = 1, 2 replicats. H WB analysis of Aβ42 at NI and 9 h p.i. with 20 or 100 µg of proteins using anti- Aβ42 C ter antibody (A1976-Sigma). Viral protein US11 as control of infection. I WB analysis of Aβ42 at NI and 9 h p.i. using anti-Aβ42 N ter antibody 6E10 (left panel) or 4G8 (right panel). J IF analysis of APP-derived isoforms in SY5Y cell line transfected (APPWT) or not (Control) for human wild type APP gene, scale bar = 10 μm. K WB analysis of Aβ42 at NI and 9 h p.i. using anti-Aβ42 C ter antibody. Viral protein US11 as control of infection.
Fig. 2 APP post-translational maturation occurs via non amyloid and amyloid pathways during infection. A Representation of APP-derived isoforms detected by anti-APP C-Ter antibody directed against the C terminal extremity of APP. B, C FACS analysis of number of APP-derived isoforms positive cells at NI and 9 h p.i. (%) using anti-APP Cter antibody (171610-Calbiochem) ****p-value < 0.0001 n = 1, 2 replicats. D WB analysis of APP-derived isoforms at NI, 3, 6 and 9 h.p.i using anti-APP Cter antibody (171610-Calbiochem). E Representation of Aβ42 detected by anti-Aβ42 specific antibody directed against C terminal cleaved extremity. F, G FACS analysis of number of Aβ42 oligomers positive cells at NI and 9 h p.i. (%) using anti-Aβ42 C ter antibody (A1976-Sigma) ****p-value < 0.0001 n = 1, 2 replicats. H WB analysis of Aβ42 at NI and 9 h p.i. with 20 or 100 µg of proteins using anti- Aβ42 C ter antibody (A1976-Sigma). Viral protein US11 as control of infection. I WB analysis of Aβ42 at NI and 9 h p.i. using anti-Aβ42 N ter antibody 6E10 (left panel) or 4G8 (right panel). J IF analysis of APP-derived isoforms in SY5Y cell line transfected (APPWT) or not (Control) for human wild type APP gene, scale bar = 10 μm. K WB analysis of Aβ42 at NI and 9 h p.i. using anti-Aβ42 C ter antibody. Viral protein US11 as control of infection.CC BY · PubMed Central
Fig. 3 Caspase dependent Aβ42 oligomers production occurs in HSV-1 infected cells. A FACS analysis of intensity of fluorescence of APP-derived isoforms positive cells at NI and 9 h p.i. using anti-APP Cter antibody (171610-Calbiochem) Fold of control: 9 h p.i /NI, n = 2. B FACS analysis of intensity of fluorescence of Aβ42 oligomers positive cells at NI and 9 h p.i. using anti-Aβ42 C ter antibody (A1976-Sigma) Fold of control: 9 h p.i /NI, n = 2. C IF analyses of Aβ42 oligomers (A1976-Sigma) at NI and 9 h p.i.Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. D Higher magnification (X100), scale bar = 10 μm. E WB analysis of caspase 3 at NI, 3, 6 and 9 h.p.i. using anti-caspase 3 antibody (9662-Cell signaling). Viral protein US11 as control of infection. F IF analyses of casp3A at 9.p.i using anti-casp3 cleaved antibody (9664-Cell signaling). Viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm. Experimental condition for G, H, I and J HSV-1 infection with or without pan-caspase inhibitor Z-VAD-fmk. G, H IF analysis of cap3A (9664-Cell signaling) and Aβ42 oligomers (A1976-Sigma) at 9 h p.i. Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. I, J FACS analysis of intensity of fluorescence of casp3A (9664-Cell signaling) and Aβ42 oligomers (A1976-Sigma) positive cells at 9 h p.i and 9 h p.i Z-VAD-fmk. Fold of control: 9 h p.i Z-VAD-fmk /9 h p.i, n = 1, 2 replicats.
Fig. 3 Caspase dependent Aβ42 oligomers production occurs in HSV-1 infected cells. A FACS analysis of intensity of fluorescence of APP-derived isoforms positive cells at NI and 9 h p.i. using anti-APP Cter antibody (171610-Calbiochem) Fold of control: 9 h p.i /NI, n = 2. B FACS analysis of intensity of fluorescence of Aβ42 oligomers positive cells at NI and 9 h p.i. using anti-Aβ42 C ter antibody (A1976-Sigma) Fold of control: 9 h p.i /NI, n = 2. C IF analyses of Aβ42 oligomers (A1976-Sigma) at NI and 9 h p.i.Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. D Higher magnification (X100), scale bar = 10 μm. E WB analysis of caspase 3 at NI, 3, 6 and 9 h.p.i. using anti-caspase 3 antibody (9662-Cell signaling). Viral protein US11 as control of infection. F IF analyses of casp3A at 9.p.i using anti-casp3 cleaved antibody (9664-Cell signaling). Viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm. Experimental condition for G, H, I and J HSV-1 infection with or without pan-caspase inhibitor Z-VAD-fmk. G, H IF analysis of cap3A (9664-Cell signaling) and Aβ42 oligomers (A1976-Sigma) at 9 h p.i. Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. I, J FACS analysis of intensity of fluorescence of casp3A (9664-Cell signaling) and Aβ42 oligomers (A1976-Sigma) positive cells at 9 h p.i and 9 h p.i Z-VAD-fmk. Fold of control: 9 h p.i Z-VAD-fmk /9 h p.i, n = 1, 2 replicats.CC BY · PubMed Central
Fig. 4 HSV-1 induced accumulation of Aβ42 oligomers and casp3A are aggresome. A IF analysis of Aβ42 oligomers (A1976-Sigma) and casp3A (9664-Cell signaling) at 6 h p.i, γ tubulin is a MTOC control (white arrow) (magnification X40), scale bar = 10 μm. B IF analysis of Aβ42 oligomers (A1976-Sigma) at 9 h p.i. Vimentin as control of aggresome formation (magnification X40), scale bar = 10 μm. C Confocal analysis of colocalization between Aβ42 oligomers and vimentin, scale bar = 10 μm. D IF analysis of Aβ42 oligomers (A1976-Sigma) at 9 h p.i with or without nocodazole treatment. Viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm. E WB analysis of Rheb (4935-Cell signaling) at NI, 6 and 9 h p.i using anti-Rheb antibody.
Fig. 4 HSV-1 induced accumulation of Aβ42 oligomers and casp3A are aggresome. A IF analysis of Aβ42 oligomers (A1976-Sigma) and casp3A (9664-Cell signaling) at 6 h p.i, γ tubulin is a MTOC control (white arrow) (magnification X40), scale bar = 10 μm. B IF analysis of Aβ42 oligomers (A1976-Sigma) at 9 h p.i. Vimentin as control of aggresome formation (magnification X40), scale bar = 10 μm. C Confocal analysis of colocalization between Aβ42 oligomers and vimentin, scale bar = 10 μm. D IF analysis of Aβ42 oligomers (A1976-Sigma) at 9 h p.i with or without nocodazole treatment. Viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm. E WB analysis of Rheb (4935-Cell signaling) at NI, 6 and 9 h p.i using anti-Rheb antibody.CC BY · PubMed Central
Fig. 5 Abortosis-like event by aggresome formation is a cellular mechanism. A Characterization of ruban type aggresome of Aβ42 oligomers and spheric type aggresome of casp3A by confocal microscopy analysis and 3D reconstructions. Aβ42 oligomers (A1976-Sigma, green signal), γ tubulin as a MTOC control (red signal), scale bar = 10 μm. B FACS analysis of casp3A positive cells using anti-casp3 cleaved antibody (9664-Cell signaling) at NI, 3, 6 and 9 h p.i., ****p-value < 0.0001 n = 1. C FACS analysis of fragmented DNA positive cells at NI, 3, 6 and 9 h p.i, ****p-value < 0.0001 n = 2. Experimental conditions for D and E: HSV-1 infection with or without ALLN treatment. D FACS analysis of fragmented DNA positive cells at NI and 9 h p.i ****p-value < 0.0001 n = 1. E IF analysis of casp3A (9664-Cell signaling) at 9 h p.i. Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. F IF analysis of casp3A (9664-Cell signaling). Vimentine as control of aggresome formation (magnification X100), scale bar = 10 μm. Experimental conditions for G, H and I staurosporine treatment with or without ALLN pre-treatment. G FACS analysis of fragmented DNA positive cells at NT and 24 h, ****p-value < 0.0001 n = 3. H IF analysis of casp3A (9664-Cell signaling) at 24 h post-treatment. Vimentine as control of aggresome formation (magnification X100), scale bar = 10 μm. I May Grünwald Giemsa coloration of cells (magnification X50) at 24 h post-treatment, scale bar = 50 μm. Cells without apoptotic phenotype indicated by black arrows.
Fig. 5 Abortosis-like event by aggresome formation is a cellular mechanism. A Characterization of ruban type aggresome of Aβ42 oligomers and spheric type aggresome of casp3A by confocal microscopy analysis and 3D reconstructions. Aβ42 oligomers (A1976-Sigma, green signal), γ tubulin as a MTOC control (red signal), scale bar = 10 μm. B FACS analysis of casp3A positive cells using anti-casp3 cleaved antibody (9664-Cell signaling) at NI, 3, 6 and 9 h p.i., ****p-value < 0.0001 n = 1. C FACS analysis of fragmented DNA positive cells at NI, 3, 6 and 9 h p.i, ****p-value < 0.0001 n = 2. Experimental conditions for D and E: HSV-1 infection with or without ALLN treatment. D FACS analysis of fragmented DNA positive cells at NI and 9 h p.i ****p-value < 0.0001 n = 1. E IF analysis of casp3A (9664-Cell signaling) at 9 h p.i. Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. F IF analysis of casp3A (9664-Cell signaling). Vimentine as control of aggresome formation (magnification X100), scale bar = 10 μm. Experimental conditions for G, H and I staurosporine treatment with or without ALLN pre-treatment. G FACS analysis of fragmented DNA positive cells at NT and 24 h, ****p-value < 0.0001 n = 3. H IF analysis of casp3A (9664-Cell signaling) at 24 h post-treatment. Vimentine as control of aggresome formation (magnification X100), scale bar = 10 μm. I May Grünwald Giemsa coloration of cells (magnification X50) at 24 h post-treatment, scale bar = 50 μm. Cells without apoptotic phenotype indicated by black arrows.CC BY · PubMed Central
Fig. 6 Flurbiprofen associated to anti-apoptotic molecule abrogate Aβ42 oligomers production in HSV-1 infected cells. Experimental conditions for A, B, C and D: HSV-1 infection with or without Z-VAD-fmk (Z), Flurbiprofen (F) and Flubriprofen (F) associated to Z-VAD-fmk (Z) treatments. A IF analysis of Aβ42 at 6 h p.i. and 9 h p.i. using anti-Aβ42 C ter antibody (A1976-Sigma). Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. B IF analysis of casp3A at 6 h p.i. using anti-casp3 cleaved antibody (9664-Cell signaling). Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. C IF analysis of Aβ42 (A1976-Sigma) at 9 h p.i. and 9 h p.i. with Flurbiprofen, viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm. D IF analysis of Aβ42 (A1976-Sigma) at 9 h p.i. with Flurbiprofen and Z-VAD-fmk, viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm (left panel). FACS analysis of intensity of fluorescence of Aβ42 oligomers positive cells (A1976-Sigma) at 9 h p.i and 9 h p.i with Flurbiprofen and Z-VAD-fmk. Fold of control: 9 h p.i Flurbiprofen and Z-VAD-fmk /9 h p.i., n = 1, 2 replicats (right panel). E HSV-1 induces the appearance of activated caspase 3 (casp3A) resulting in caspase-dependent cleavage of APP. This leads to the production of Aβ42 peptides. Casp3A and Aβ42 are two pro-apoptotic factors that should induce apoptosis and therefore neuronal death. F However, HSV-1 induces simultaneously to the production of casp3A and Aβ42 peptides, the formation of intra-cytoplasmic aggresomes in which these two factors accumulate. This cytoplasmic sequestration precludes apoptosis to proceed until late stages. This phenomenon, called abortosis allows neuronal cell survival and a chronic production of Aβ42.
Fig. 6 Flurbiprofen associated to anti-apoptotic molecule abrogate Aβ42 oligomers production in HSV-1 infected cells. Experimental conditions for A, B, C and D: HSV-1 infection with or without Z-VAD-fmk (Z), Flurbiprofen (F) and Flubriprofen (F) associated to Z-VAD-fmk (Z) treatments. A IF analysis of Aβ42 at 6 h p.i. and 9 h p.i. using anti-Aβ42 C ter antibody (A1976-Sigma). Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. B IF analysis of casp3A at 6 h p.i. using anti-casp3 cleaved antibody (9664-Cell signaling). Viral protein ICP8 as control of infection (magnification X40), scale bar = 10 μm. C IF analysis of Aβ42 (A1976-Sigma) at 9 h p.i. and 9 h p.i. with Flurbiprofen, viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm. D IF analysis of Aβ42 (A1976-Sigma) at 9 h p.i. with Flurbiprofen and Z-VAD-fmk, viral protein ICP8 as control of infection (magnification X100), scale bar = 10 μm (left panel). FACS analysis of intensity of fluorescence of Aβ42 oligomers positive cells (A1976-Sigma) at 9 h p.i and 9 h p.i with Flurbiprofen and Z-VAD-fmk. Fold of control: 9 h p.i Flurbiprofen and Z-VAD-fmk /9 h p.i., n = 1, 2 replicats (right panel). E HSV-1 induces the appearance of activated caspase 3 (casp3A) resulting in caspase-dependent cleavage of APP. This leads to the production of Aβ42 peptides. Casp3A and Aβ42 are two pro-apoptotic factors that should induce apoptosis and therefore neuronal death. F However, HSV-1 induces simultaneously to the production of casp3A and Aβ42 peptides, the formation of intra-cytoplasmic aggresomes in which these two factors accumulate. This cytoplasmic sequestration precludes apoptosis to proceed until late stages. This phenomenon, called abortosis allows neuronal cell survival and a chronic production of Aβ42.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. Whitley RJ, Gnann Jr. JW, eds. The epidemiology and clinical manifestations of herpes simplex virus infections. New York: Raven press; 1993.

Cited by

See all 25

Metadata

Authors
Albaret, M. A., Textoris, J., Dalzon, B., Lambert, J., Linard, M., Helmer, C., Hacot, S., Ghayad, S. E., Ferréol, M., Mertani, H. C., & Diaz, J.-J.
Affiliations
  • Lyon 1 Université (FR)
  • Centre National de la Recherche Scientifique (FR)
  • Université de Bordeaux (FR)
  • Inserm (FR)
  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
Corresponding author
  • Albaret, Marie Alexandra
  • Diaz, Jean-Jacques
Venue
Translational Psychiatry
Published
2023-03-10
Volume
13
Issue
1
Pages
86-86
ISSN
2158-3188 (ISSN-L)
OpenAlex
W4323920955
Cited by
25
References
52
Citations by year
2026: 5 · 2025: 9 · 2024: 9 · 2023: 2
FWCI
0.89
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion, cc-by)
Funders
CNRS, INSERM, Université Claude Bernard Lyon-1 and DevWeCan Labex Laboratory
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, herpes simplex virus type 1, aggresomes, caspase-3, apoptosis, viral infection, amyloid precursor protein, flurbiprofen, nonsteroidal anti-inflammatory drugs, caspase inhibitors, sporadic Alzheimer's disease
MeSH terms
Alzheimer Disease, Anti-Inflammatory Agents, Non-Steroidal, Humans, Neurons, Peptide Fragments, Amyloid beta-Peptides, Herpesvirus 1, Human, Caspases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41398-023-02376-8
The paper
Albaret, M. A., Textoris, J., Dalzon, B., Lambert, J., Linard, M., Helmer, C., Hacot, S., Ghayad, S. E., Ferréol, M., Mertani, H. C., & Diaz, J.-J. (2023). HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease. Translational Psychiatry. https://doi.org/10.1038/s41398-023-02376-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.